pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Johns Hopkins University

updated 5mo ago

Johns Hopkins University is a private research university in Baltimore, Maryland, United States. Incorporated in 1867 and opened in 1876 based on the European research institution model, Johns Hopkins is considered to be the first research university in the U.S.

community read0 votes

🐶 often sniffed alongside

top 8
  • tagImmunology7 co-mentions · 7 sources
  • tagPulmonology5 co-mentions · 5 sources
  • drugateganosine4 co-mentions · 4 sources
  • tagOphthalmology2 co-mentions · 2 sources
  • tagInfectious Disease2 co-mentions · 2 sources
  • tagPsychiatry & CNS2 co-mentions · 2 sources
  • tagNeurology1 co-mentions · 1 sources
  • tagCardiology1 co-mentions · 1 sources
pipeline
0
marketed
0
phase 3
0
catalysts ytd
37
approvals ytd
0
recalls ytd
0

Pipeline(0)

no pipeline products on record

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase2Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndromerecruitingn=10
  • N/ATreating Traumatic Brain Injury With Transcranial Direct Current Stimulationnot yet recruitingn=20
  • phase2Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorderrecruitingn=105
  • phase2Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPDrecruitingn=334
  • —Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF Patientsactive not recruitingn=60
  • —Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumabenrolling by invitationn=75
  • —Multimodal Glucose Prediction in Type 2 Diabetesnot yet recruitingn=36
  • N/AWIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Preventionrecruitingn=400
🐶 Hiring Signal
No open roles indexed yet — view Johns Hopkins University jobs →

News

  • New lawsuit argues NIH violated First Amendment rights of grant applicants
    The lawsuit seeks to halt the process of searching grant applications for specific terms to determine if they should be rejected.
    stat · 13d ago
  • After a brief storm of political headwinds, mRNA is back with strong momentum
    A year to the day after the Trump administration slashed $500 million in funding from mRNA-based programs, the FDA approved Moderna’s flu vaccine based on the technology. Weeks later, Moderna and M…
    biospace · 16d ago
  • FDA solidifies CDER, CBER leadership posts as commissioner confirmation awaits
    In a stabilizing move, the Department of Health and Human Services announced Tuesday afternoon that it has tapped Michael Davis, M.D., Ph.D., and Karim Mikhail—who’ve been serving as acting directo…
    fiercebiotech · 21d ago
  • Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?
    The announcement from Merck & Co. and Moderna last month that their mRNA cancer vaccine had successfully lengthened patient survival in a phase 3 study affirmed the two companies' years of hard wor…
    fiercebiotech · 29d ago
  • Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?
    Urologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional surgery or radiation.
    stat · 1mo ago
  • Trump nominates policy aide Overton to lead FDA
    Heidi Overton, a medical doctor and veteran of the America First think tank, currently serves as deputy director of the White House Domestic Policy Council.
    biopharma_dive · 1mo ago
  • Trump taps White House aide Heidi Overton as nominee for next FDA commissioner
    After three months without a permanent leader in place, President Donald Trump has named his pick for the new commissioner of the FDA. Heidi Overton, M.D., Ph.D., currently a White House aide, will…
    fiercebiotech · 1mo ago
  • Opinion: We proved bipartisan health care reform works in North Carolina. Let’s bring it nationwide
    “North Carolina proved that pragmatism can beat partisanship,” write Mandy Cohen and Kody Kinsley.
    stat · 1mo ago
  • IRBs have a problem. Can North Star’s nonprofit model save it?
    As institutional review boards face pressure from companies and ethicists, North Star Review Board offers a nonprofit model as more independent.
    stat · 1mo ago
  • Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was
    “The United States invented this platform and is the only country walking away from it,” Jeff Coller writes of mRNA vaccines.
    stat · 1mo ago
view all news mentions →
identifiers
source
globaldata
mentioned in
10news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?